Results 191 to 200 of about 132,458 (343)

Letrozole at the Crossroads of Efficacy and Fetal Safety in Ovulation Induction: A Narrative Review. [PDF]

open access: yesBiomedicines
Kaltsas A   +9 more
europepmc   +1 more source

Looking for the Best Way to Come Off Steroids Safely? Exploring Post‐Cycle Therapy, Cessation, and Recovery Discourse and Practice in Australian Steroid Consumer Forums

open access: yesDrug and Alcohol Review, EarlyView.
ABSTRACT Introduction Anabolic‐androgenic steroid (AAS) use is rising in Australia; however, discontinuation poses challenges due to withdrawal symptoms and a lack of clinical guidance. Therefore, the aim of this study was to explore online discourses around post‐cycle therapy (PCT), including perceived health risks, benefits and barriers, among people
Jonathan Easton   +4 more
wiley   +1 more source

Case Report: Hypergonadotropic hypogonadism in an elite athlete with variant in FSH receptor gene-clinical and sports implications of proper diagnosis. [PDF]

open access: yesFront Endocrinol (Lausanne)
Skrzypiec-Spring M   +5 more
europepmc   +1 more source

Infertility management in resistant ovary syndrome: a review. [PDF]

open access: yesFront Endocrinol (Lausanne)
Yi H   +5 more
europepmc   +1 more source

Treatment Persistence Was High When Hormone Therapy for Gender Incongruence Included Comprehensive Diagnoses and Interdisciplinary Care During Adolescence

open access: yes
Acta Paediatrica, EarlyView.
Katharina Feil   +6 more
wiley   +1 more source

Repurposing colchicine for reduction of residual inflammatory risk in type 1 diabetes: Design and rationale of the REC1TE trial

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Aims Compared to people without diabetes, individuals with type 1 diabetes have a several‐fold increased risk of cardiovascular (CV) morbidity and mortality despite guideline‐recommended management of traditional risk factors; so‐called residual CV risk.
David S. Mathiesen   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy